CD8A and colorectal carcinoma: The 5-year survival in patients with early-stage CRC revealed better prognosis for individuals with lower fractions of CD8+ T cells (HR = 3.8167, 95% CI [1.4706-9.9072], p = 0.0116), based on CIBERSORT analysis (Figure 5A).